Cadence vs Dimer Health
Both put clinicians and software around a patient at home and they choose different moments to do it. Cadence runs continuous chronic care management for older adults, watching daily vitals for hypertension, diabetes, heart failure and lung disease, and it publishes the proportion of alerts its supervised agents close without a human, which is a rare and creditable disclosure. Dimer is clinician led transitional care, concentrated on the period immediately after discharge when readmission risk is highest and the patient is least supported. These are different budgets and different owners: chronic care management is an ongoing programme with a billing pathway, transitional care is an episode aimed at a penalty. The question is not which is better but which failure your organisation is currently paying for, and the answer is usually visible in your readmission numbers.
- It publishes an autonomous resolution rate for its agents rather than describing supervision, which makes the human in the loop claim checkable rather than rhetorical.
- It is delivered in partnership with health systems and billed through chronic care management, so it fits an existing reimbursement pathway rather than requiring a new budget line.
- Conditions and population are enumerated precisely, which lets a buyer match the programme against its own attributed panel rather than against a general claim.
- The clinical model is different in kind: clinician led transitional care aimed at the days after discharge, which is where avoidable readmission is decided.
- Transitional care is a bounded episode with a measurable endpoint, so the programme's effect is easier to attribute than an ongoing monitoring service.
- For an organisation whose penalty exposure is readmissions rather than chronic disease control, the intervention window matters more than the monitoring breadth.
Side by Side
| Axis | C Cadence |
D Dimer Health |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Remote Monitoring & Chronic Care page.
Both vendors sell a clinical service with software attached, so the comparison is partly a staffing decision and the pricing should be read against the cost of running the equivalent programme internally. Cadence publishes no security attestation, trust centre, retention position or training use statement, and its record system integration is claimed without documentation. Neither vendor publishes subgroup performance.
In remote monitoring, adherence and connectivity vary with income, age and housing stability, and a patient whose device stops reporting is indistinguishable from a patient who is doing well, which is the failure mode both programmes should be asked how they detect.